Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 21Triple Negative Breast Neoplasms 12Inflammatory Breast Neoplasms 2Carcinoma, Adenoid Cystic 2Resectable HER2-positive Breast Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-Muscle Invasive Bladder Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Hodgkin Disease 1HR+/HER2- Breast Cancer 1Epstein-Barr Virus Infections 1Down Syndrome 1CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

pembrolizumab 4lenvatinib 3Magnetic Resonance Spectroscopy 3Specimen Handling 2Nivolumab 2Epirubicin 2regorafenib 1gallium 68 PSMA-11 1enfortumab vedotin 1anlotinib 1amivantamab 1abemaciclib 1Tablets 1Surveys and Questionnaires 1Standard of Care 1Radiosurgery 1Pemetrexed 1Observation 1Ipilimumab 1Imatinib Mesylate 1Glutamate Carboxypeptidase II 1Cyclophosphamide 1Combined Modality Therapy 1Carboplatin 1CTLA-4 Antigen 1Blood Specimen Collection 1BMS-906024 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Adenoid Cystic × Epirubicin × 1 year × Clear all
NCT07616141 2026-06-01

NAET4-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Not yet recruiting
76 enrolled

Carcinoma, Adenoid Cystic

NCT07320508 2026-05-12

EIC-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Recruiting
100 enrolled

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡